Yasmine Wasfi - 04 Dec 2025 Form 4 Insider Report for Savara Inc (SVRA)

Role
Chief Medical Officer
Signature
/s/ Kate McCabe as attorney-in-fact for Yasmine Wasfi
Issuer symbol
SVRA
Transactions as of
04 Dec 2025
Net transactions value
-$140,089
Form type
4
Filing time
04 Dec 2025, 18:57:10 UTC
Previous filing
22 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wasfi Yasmine Chief Medical Officer ONE SUMMIT SQUARE,, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300, LANGHORNE /s/ Kate McCabe as attorney-in-fact for Yasmine Wasfi 04 Dec 2025 0002092127

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SVRA Common Stock Tax liability $140,089 -21,992 -12% $6.37 168,008 04 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units.